Insight,

Compliance Management for Importing Biological Materials

CN | EN
Current site :    CN   |   EN
Australia
China
China Hong Kong SAR
Japan
Singapore
United States
Global

The import of biological materials has been strictly supervised under the Chinese import regulatory regime. On April 15, 2021, The Biosecurity Law of P.R.C. (“Biosecurity Law”) was officially implemented, which strengthens the supervision on the application of biology technology. The Biosecurity Law and other existing regulations and rules establish a national administration system for imported biological materials. 

This article intends to highlight key regulatory requirements for importing biological materials and assist biotech companies in the compliance management related to importing biological materials. 

I. Key Regulatory Requirements for the Import of Biological Materials

As preconditions for importing, the biological materials must be declared to the Customs and go through health and quarantine inspection, and the approval certificate issued by the Customs for Special Articles should be obtained.

1. Biological Materials under Regulation

According to the Administrative Provisions on Health Quarantine for Entry or Exit of Special Articles (the “Special Articles Quarantine Provisions”), the biological materials are defined as “Special Articles” including microbes, human tissues, biological products, blood and its products, etc., details as follows:


2. Quarantine Approval

According to the Implementing Rules of Border Health and Quarantine Law and the Special Articles Quarantine Provisions, the General Administration of Customs of PRC is uniformly in charge of the national supervision and administration of entry and exit health quarantine on Special Articles. The competent Customs shall be responsible for the supervision and administration of entry and exit health quarantine on Special Articles within their own jurisdictions.

Before the import of Special Articles, the importer shall submit the required documents to the Customs to apply for the approval of the Special Articles quarantine and obtain the Certificate of Approval of Health Quarantine for Entry or Exit of Special Articles (“Certificate of Approval of Special Articles”). 

3. Quarantine Inspection and Examination

After the Special Articles arrive at the port of entry, the importer shall declare to the Customs at the port of entry with the Certificate of Approval of Special Articles and other documents. The Customs at the port of entry will release the Special Articles after they pass the inspection and examination of health quarantine. 

4. Subsequent Supervision and Administration

For the imported Special Articles subject to subsequent supervision (including those containing or likely to contain microbes, toxins and other biological hazards), the organization which uses such Special Articles shall declare to the Customs at destination within 30 days after the import, and the Customs at destination shall implement the subsequent supervision and administration thereon.

II. Potential Implications

In recent years, Customs across the country have dealt with a number of cases of illegal import of biological materials. For example, in May of 2021, Shanghai Customs intercepted 247 items hiding human cells when inspecting imported goods named “laboratory medium”.

1. Risks of Administrative Penalties

According to the Special Articles Quarantine Provisions, the Customs shall order the biological materials without obtaining or inconsistent with the Certificate of Approval of Special Articles, to be returned or destroyed. In addition, the importers of the goods may also be imposed with a fine no more than RMB 30,000.

Although the amount of administrative fine is not overwhelmingly huge, the administrative penalties of the Customs will directly degrade the customs credit rating of the importer. Such degradation will bring serious supervision on the import and export activities of the importer, e.g. more port inspections. 

2. Risks of Illegal Smuggling or Smuggling Crime

If the importers of goods have the intention to smuggle biological materials and bring the biological materials into the border of PRC, which do not comply with above requirements for quarantine approval and quarantine inspection, through the approaches of deliberately concealed declaration, misrepresentation or secret carry, etc., the activities may constitute illegal smuggling under Customs Law or the crime of smuggling under Criminal Law if the circumstance is serious.

Suggestion

In order to prevent legal risks related to importing biological materials, it is suggested that enterprises engaged in importing and/or using imported biological materials should strengthen compliance management, including:

1. The importer should faithfully declare the goods with Customs, apply for the approval, examination and quarantine for importing biological materials strictly in accordance with the Special Articles Quarantine Provisions and other relevant customs regulations. Enterprises must not conceal, falsely declare or secretly carry biological materials into the border of PRC. 

2. The enterprise should (i) establish a security management system for the use, sale and scientific research of imported biological materials, (ii) produce, use or sell biological materials strictly in accordance with the purposes approved, and (iii) keep authentic records of production, use and sale of imported biological materials for no less than two years.

3. Enterprises purchasing imported biological materials in China should strictly conduct supplier audit, require the suppliers to provide the Certificate of Approval of Special Articles regarding the relevant batch of biological materials and require them to make compliance commitment for the imported biological materials.

 Scan the code to download the article
LATEST THINKING
Insight
As the revision of the Arbitration Law of the People’s Republic of China (“PRC Arbitration Law”) progresses, ad hoc arbitration is gaining more attention in China. Previously, there was discussion on whether ad hoc arbitration will truly take root in the country. Recently, there have been notable advancements in the adoption of practical rules surrounding ad hoc arbitration in certain regions while on the national level, there appears to be more of a cautious stance in expanding the scope of ad hoc arbitration. This article provides a brief summary of these developments, starting with a national perspective and discussion of the key issues regarding the draft amendments to the PRC Arbitration Law. The article then ends with an overview of regional efforts to introduce ad hoc arbitration, including initiatives under the current regional system in Shanghai.dispute resolution and litigation-domestic arbitration

14 March 2025

Insight
On January 12, 2025, the Guangdong Provincial Government introduced the Measures for High-Quality Development of Capital Markets to Support Guangdong’s Modernization (the “Measures”). These Measures lay out a detailed framework aimed at strengthening Guangdong’s multi-tiered capital markets, boosting tech-driven enterprises, and improving the overall quality of listed companies. The overarching goal is to position Guangdong as leading financial hub and embrace innovation to attract global investment.

07 March 2025

Insight
On January 16, 2025, the General Office of the Shanghai Municipal People’s Government released the Implementation Plan for Promoting the High-Quality Development of Digital Trade and Service Trade in Shanghai (the “Implementation Plan”). This strategic blueprint aims to establish Shanghai as a global hub for digital trade, which includes digital products, and technology-driven trade, as well as service trade, covering sectors such as finance, insurance, logistics, and cultural services. With a strong focus on reform, innovation, and the opening of key sectors, the Implementation Plan sets out a series of priorities and actionable steps to achieve these goals by 2029.

07 March 2025